Yuandong Tao

Dr. Yuandong Tao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2025 in The Visual Computer
Verified
Journal Article
Closed access
PDF file
XZXuefeng Zhang
Xuefeng Zhang
BYBin Yan
Bin Yan
ZXZhaohu Xing
Zhaohu Xing
FGFeng Gao
Feng Gao
YTYuandong Tao
Yuandong Tao
LZLei Zhu
Lei Zhu

8 April 2025 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
HCHualin Cao
Hualin Cao
YWYangyang Wu
Yangyang Wu
PLPin Li
Pin Li
XYXiaoyu Yi
Xiaoyu Yi
XZXiaowei Zhang
Xiaowei Zhang
YTYuandong Tao
Yuandong Tao

13 May 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
GYGuang Yue
Guang Yue
YYYunjie Yang
Yunjie Yang
HJHongshuai Jia
Hongshuai Jia
YWYangyang Wu
Yangyang Wu
LMLifei Ma
Lifei Ma
YTYuandong Tao
Yuandong Tao
Obstructive nephropathy is one of the leading causes of kidney injury and fibrosis, which can lead to end-stage renal disease (ESRD). Stromal vascular fraction (SVF), a heterogeneous cell mixture derived from adipose tissue, has been widely used for regenerative medicine across many preclinical models and clinical applications. Recent studies have suggested that SVF can alleviate acute kidney injury in mice. However, to our knowledge, the therapeutic effects of SVF on obstructive nephropathy have not been studied before. In this study, we evaluated the therapeutic potential of SVF on obstructive nephropathy in mice with unilateral ureteral obstruction (UUO). We revealed that autologous SVF administration mitigated UUO-induced renal fibrosis. SVF treatment inhibited both the infiltration of neutrophils and CD4+ T cells, as well as the production of inflammatory cytokines. Moreover, SVF promoted metabolic reprogramming and improved mitochondrial function in the obstructed kidneys, partially through PPAR pathway activation. Mechanistically, SVF-mediated PPAR activation inhibited the epithelial-mesenchymal transition (EMT) process of tubular cells, thus alleviating renal fibrosis in UUO mice. We further confirmed that pharmacological activation of PPAR pathway significantly reduced fibrosis in UUO kidneys. Therefore, our study suggests that SVF may represent a promising therapeutic strategy for obstructive nephropathy.

22 July 2025 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
YWYangyang Wu
Yangyang Wu
HCHualin Cao
Hualin Cao
PLPin Li
Pin Li
YZYang Zhao
Yang Zhao
TTTian Tao
Tian Tao
YTYuandong Tao
Yuandong Tao